Polymorphisms in PDCD1 gene are not associated with Wegener’s granulomatosis
✍ Scribed by Priya Sakthivel; Ricardo Giscombe; Ryan Ramanujam; Ann Kari Lefvert
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 209 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background Olanzapine is an atypical antipsychotic known to cause considerable weight gain. The cannabinoid type 1 receptor has been reported to be involved in energy balance control, appetite stimulation, and increases in body weight. Methods In the present study, we investigated three polymorphism
## Abstract ## Objective Wegener's granulomatosis (WG) and Churg‐Strauss syndrome (CSS) belong to the heterogeneous group of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides. Current understanding of their pathogenesis and genetic background is limited. Expression levels of inter
## Abstract CYP1A1 is likely to play an important role in the etiology of CaP through its function in activating environmental procarcinogens and catalyzing the oxidative metabolites of estrogens. To test the hypothesis that genetic polymorphisms in the __CYP1A1__ gene may be associated with the ri